About: Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2000 (uk) im Mai 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2000 (ast) scientific article published on 01 May 2000 (en)
publication date	wds:Q73896111-5DC017A2-EEBD-4552-A2F1-09918D8FD1AA
publication date	2000-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73896111-4A0CE881-A33D-4A3F-9221-314C8BED342B wds:Q73896111-6D57E1C9-885B-459A-B94A-E4E4BE449E88 wds:Q73896111-A6883D9B-0986-4770-AE82-8BC18FB369F9 wds:Q73896111-A8E1C68F-76B8-4A7E-8A0A-98CBEEDB6E56 wds:Q73896111-A9F4BB8F-AB8B-418E-8732-C98EAA8AFE88 wds:Q73896111-FA4CD49D-F457-4350-B8CD-C4D8839EAE88
author name string	W C Hop J A van Noord T A Bantje A M Bommer D R de Munck M L Akveld
rdfs:label	Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium (en) Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium (nl)
skos:prefLabel	Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium (en) Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium (nl)
name	Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium (en) Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium (nl)
title	wds:Q73896111-889443FE-F805-4233-A4AA-27A5527D3B80
title	Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium (en)
page(s)	wds:Q73896111-29840BD1-94DE-4D3B-88A6-3BA00BBD669A
page(s)	878-885
instance of	wds:Q73896111-1CB15F07-DEC7-41D6-89B6-65F765F3158A
instance of	scholarly article
main subject	wds:Q73896111-DD3CF734-C6FC-40DF-95E1-B63651E594D1
main subject	chronic obstructive pulmonary disease
PubMed ID	wds:Q73896111-77175621-A830-48B3-92A4-1B0A91B45A5A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10853852
PubMed ID	10853852
published in	wds:Q73896111-8B371250-A7ED-4DCE-AF05-A5E4E71A8D0B
published in	European Respiratory Journal
issue	wds:Q73896111-E5DD170F-E76D-41B8-87B8-ED78DD9E5E05
volume	wds:Q73896111-8B3F3853-288E-4AC4-A327-5B6C5C63D4F8
issue	5
volume	15
DOI	wds:Q73896111-A3D1D310-EC2D-486B-8E5C-C1C3166E99D3
DOI	http://dx.doi.org/10.1034/J.1399-3003.2000.15E11.X
DOI	10.1034/J.1399-3003.2000.15E11.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73896111
is cites work of	Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease New treatments for COPD. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review Long-term pharmacologic management of patients with chronic obstructive pulmonary disease Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis Knowledge and attitudes of family physicians coming to COPD continuing medical education COPD exacerbations: defining their cause and prevention Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents Treatment of stable chronic obstructive pulmonary disease Addition of salmeterol to existing treatment in patients with COPD: a 12 month study Tackling COPD: a multicomponent disease driven by inflammation Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease Chronic obstructive pulmonary disease . 7: Management of COPD Interventions to prevent chronic obstructive pulmonary disease exacerbations. Pharmacological treatment of chronic obstructive pulmonary disease A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis Chronic obstructive pulmonary disease Underdiagnosed asthma in South Australia. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease? Optimizing bronchodilator therapy in emphysema Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease Long-acting beta2-agonists for chronic obstructive pulmonary disease Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence Treatment of chronic obstructive pulmonary disease in older patients: a practical guide Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids Tiotropium bromide Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients The pharmacological approach to the elderly COPD patient Medical management of chronic obstructive pulmonary disease Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD Daytime symptoms of chronic obstructive pulmonary disease: a systematic review Copd. Combined salmeterol and fluticasone for COPD Reference list Management of the symptomatic patient [Efficient treatments for COLD in the twenty-first century?] Copd
is cites work of	wds:Q24245141-59DE9DB3-E1B6-494F-BDA4-79AE5D57C315 wds:Q35925436-01075455-10B4-49DE-94AE-FE6C70F3C6FF wds:Q37804908-152C8722-5040-474B-BE4E-8B46179800AE wds:Q36779343-8B96591C-9828-4C74-B452-970BEF5D9344 wds:Q37017344-67B370FA-FABA-40DC-B301-B2FD9E8F927A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software